- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02362113
Glycemic Index/ Load and Mental Disorders
Glycemic Index, Glycemic Load and Common Psychological Disorders
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Frequency of 5 food groups will be asked in dish-based semi-quantitative food frequency questionnaire and they would be converted to grams. GI and GL will be estimated by using international table of GI and GL.
Validated Iranian versions of Hospital Anxiety and Depression Scale and General Health Questionnaire (GHQ)-12 were used to assess anxiety, depression and psychological distress.
Possible score range for anxiety and depression is from 0 to 21. Scores of 8 or higher on either section were considered as the presence of anxiety or depression and scores of 7 or less were considered as normal status. In the present study, participants who got scores of 4 or more from GHQ were considered to have psychological distress.
Study Type
Enrollment (Anticipated)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Men and women aged 18-75 years of free-living individuals.
Exclusion Criteria:
- Over or underestimating of total energy intake
- Uncompleted questionnaire (more than 30% of questions)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Isfahani adults
GI/GL
|
GI and GL would be categorized as tertile.
due to cross-sectional design of this study, intervention would not be applicable.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
odds ratio for having depression resulted from statistical analysis
Time Frame: up to 4 months
|
up to 4 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
depression score resulted from Hospital Anxiety and Depression Scale
Time Frame: up to 6 months
|
up to 6 months
|
Collaborators and Investigators
Investigators
- Study Chair: Peyman Adibi, MD, Integrative Functional Gastroenterology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1364
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Bekelu Teka WorkuJimma UniversityNot yet recruitingPrenatal Depression | Mental Health Related Quality of Life | Maternal Postpartum Depression | Paternal Postpartum DepressionEthiopia
Clinical Trials on GI/GL
-
University of TorontoUnknownCardiovascular Diseases | Obesity | Diabetes Mellitus, Type 2 | Body WeightCanada
-
University of TorontoToronto 3D Knowledge Synthesis and Clinical Trials foundationUnknownObesity | Cardiovascular Disease | Diabetes | Overweight | Metabolic Syndrome | Prediabetes
-
Pennington Biomedical Research CenterGeneral MillsCompleted
-
Memorial Sloan Kettering Cancer CenterGenelux CorporationCompleted
-
Motus GI Medical Technologies LtdCompleted
-
Glac Biotech Co., LtdTerminatedChronic Obstructive Pulmonary Disease | Type 2 DiabetesTaiwan
-
Gliknik Inc.RecruitingImmune ThrombocytopeniaUnited Kingdom
-
Genelux GmbHCompletedA Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal CarcinomatosisPeritoneal CarcinomatosisGermany
-
Genelux GmbHGenelux CorporationCompletedAdvanced Cancers (Solid Tumors)United Kingdom
-
Genelux CorporationNo longer availableAdvanced Stage Cancer (Solid Tumor Disease for 4 Patients) | Acute Myeloid Leukemia (6 Patients)United States